Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Structural switching of the bifunctional Chlamydia trachomatis protein, Scc4
NC - MH Hrd-Growth, Retention Opportunities for Workers
Campylobacter Jejuni Cytotoxins
Radiographic Manifestations of the Nevoid Basal Cell Carcinoma Syndrome
REU Site in Algebra, Combinatorics, Matrix Theory, and Number Theory
Recently added grants:
In Host Evolution of Nontuberculous Mycobacteria in Cystic Fibrosis
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
Detailed analysis of Cryptosporidium non-coding gene expression
VTCN1 regulation of MHC in early human placental development
Mechanism(s) of pathogenicity for Candida auris
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025120-002
Application #
6828864
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant